What’s New for Itch
Dermatologists are well aware of the difficulty in managing itchy patients. Itch can be caused by a number of cutaneous and extracutaneous diseases. Regardless of the etiology, itch is one of the most frustrating symptoms of patients and management dilemmas for dermatologists. At the 16th Annual ODAC conference, Dr. Brian Berman reviewed some of the emerging therapies for the treatment of itch a …
Dermatologists are well aware of the difficulty in managing itchy patients. Itch can be caused by a number of cutaneous and extracutaneous diseases. Regardless of the etiology, itch is one of the most frustrating symptoms of patients and management dilemmas for dermatologists. At the 16th Annual ODAC conference, Dr. Brian Berman reviewed some of the emerging therapies for the treatment of itch a … 
JDD Podcast Recap and Author Interview
Podcast host Dr. Adam Friedman sat down with Dr. David Rosmarin, Assistant Professor of Dermatology and Residency Program Director at Tufts University School of Medicine, to dive into what he learned from performing a retrospective chart review and how his work and his experience guides his clinical decision making when managing psoriasis. Here are the high … 
During the 16th Annual ODAC, Derm In-Review, in partnership with the George Washington School of Medicine and Health Sciences, hosted a 4-hour Board Review workshop led by Dr. Adam Friedman. Mid-way through the workshop, during a brain-break panel, faculty members and recently minted board-certified dermatologists, myself included, weighed in on questions related to Board Exam preparation. Residen … 
Aesthetic derm experts Dr. Terrence Keaney and Dr. Deirdre Hooper share pearls on addressing the unique needs of male and female cosmetic patients.
The Male Aesthetic Consultation
Male cosmetic patients should be evaluated differently: both anatomy and behavioral differences set male and female patients apart.
[caption id="attachment_5981" align="alignright" width="195"] "11" patter … 
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be … 